Visura Technologies Presents TEECAD Real-World Clinical Data at ASE 2023
MINNEAPOLIS, June 20, 2023 /PRNewswire/ -- Visura Technologies, Inc., a privately-held medical device company dedicated to delivering state-of-the-art visualization solutions to improve the safety and success of transesophageal echocardiogram (TEE) probe intubations, announced today it will be attending the American Society of Echocardiography's (ASE) 34th Annual Scientific Sessions in Baltimore, MD June 23-26. At this year's meeting, the TEECAD system will be highlighted in an abstract poster presentation by Sunil Mankad MD, Professor of Medicine, and Director of Transesophageal Echocardiography at the Mayo Clinic in Rochester, MN on Sunday, June 25 at 2:00 pm. In addition, Visura will release a new 15 patient TEECAD white paper from a world-renowned heart center.
- In addition, Visura will release a new 15 patient TEECAD white paper from a world-renowned heart center.
- "The presentation of the clinical data from Mayo Clinic is an important milestone for Visura and real-time visualization for TEE procedures," said David Marmor, Cardiologist at Shaare Zedek Medical Center in Jerusalem, Israel and Founder of Visura Technologies.
- Clinical data continues to support the need for sighted-TEE intubation to reduce TEE-related complications and increase first pass intubation success.
- Visit Visura and the TEECAD Innovation Station at ASE booth 513 to learn more.